Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
09
2026

Is There an Alternative to Mohs Surgery for Non-Melanoma Skin Cancer?

Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…

September
11
2017

Sensus Healthcare Cancels Presentation to Rodman & Renshaw Global Investment Conference due to Hurricane Irma

BOCA RATON, Fla., Sept. 11, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that…

September
05
2017

Skin Cancer Treatment: No Cutting, No Scarring, No Long Recovery Times

If you are one of the 3.5 million Americans diagnosed with non-melanoma skin cancer, you have a choice. Skin cancer treatment does not have to be a nightmare. With the SRT-100, patients can choose no…

September
05
2017

SRT: Innovating a Proven Treatment for Skin Cancer Treatment

Innovating upon a tried-and-true technology, an updated device is available for dermatologists to use to fight skin cancer. By Jeffrey Fromowitz, MD, FAAD As a dermatologist in practice in Boca Raton, FL, I am at…

September
05
2017

Sensus Healthcare to Present at Upcoming Investor Conferences

Management unable to present at Liolios Gateway conference due to Hurricane Irma   BOCA RATON, Fla., Sept. 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry